Evidence map›Paper›PMID 33193186›Full record

ArticleFrontiers in microbiology2020

Novel Chromosomal Mutations Responsible for Fosfomycin Resistance in

Vincent Cattoir, Annabelle Pourbaix, Mélanie Magnan, Françoise Chau, Victoire de Lastours, Brice Felden, Bruno Fantin, François Guérin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Cranberry juice potentiates sensitivity of uropathogenicApplied and environmental microbiology · 2026
    Article
  3. Genomic Characterisation of Pyometra-AssociatedAntibiotics (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Prevalence and the Underlying Mechanisms of Fosfomycin Resistance ofInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Bacteriological and molecular study of fosfomycin resistance in uropathogenic Escherichia coli.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  13. Inactivation ofMicrobiology spectrum · 2023
    Article
  14. Fosfomycin resistance mechanisms inFrontiers in cellular and infection microbiology · 2023
    Review
  15. Emergence of Fosfomycin Resistance by Plasmid-MediatedAntibiotics (Basel, Switzerland) · 2022
    Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Vincent CattoirCHU de Rennes, Service de Bactériologie-Hygiène Hospitalière, Rennes, France.
Annabelle PourbaixIAME, UMR-1137, Inserm and Université de Paris Diderot, Paris, France.
Mélanie MagnanIAME, UMR-1137, Inserm and Université de Paris Diderot, Paris, France.
Françoise ChauIAME, UMR-1137, Inserm and Université de Paris Diderot, Paris, France.
Victoire de LastoursIAME, UMR-1137, Inserm and Université de Paris Diderot, Paris, France.
Brice FeldenInserm, Bacterial Regulatory RNAs and Medicine - UMR_S 1230, Rennes, France.
Bruno FantinIAME, UMR-1137, Inserm and Université de Paris Diderot, Paris, France.
François GuérinCHU de Caen, Service de Microbiologie, Caen, France.
Université Paris Cité · FRBacterial RNAs & MedicineCentre Hospitalier Universitaire de Rennes · FRDélégation Paris 7 · FRUniversité de Caen Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fosfomycin resistance in

Indexed as

E. colifosfomycin-resistantgalUlonuhpBuhpC

Identifiers

PMID33193186
PMCPMC7607045
OpenAlexW3094583552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.